The influence of parenteral protein intake on electrolyte disturbances in premature infants

Carlos Javier Parramón-Teixidó1, Laura Gómez-Ganda1, Beatriz Garcia-Palop1

  • 1Pharmacy Service, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Anales De Pediatria
|September 11, 2021
PubMed

Insights

Aggressive parenteral nutrition (PN) in preterm infants did not increase electrolyte imbalances like hypercalcaemia or hypophosphataemia. This study found no significant difference in electrolyte disturbances between low and high amino acid doses in PN for VLBW infants.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Clinical Chemistry

Background:

  • Parenteral nutrition (PN) with high amino acid and energy doses is standard for very low birth weight (VLBW) infants to enhance growth and neurodevelopment.
  • Emerging evidence suggests this aggressive approach may lead to electrolyte disturbances.
  • This study investigates the relationship between amino acid dosage in PN and electrolyte imbalances in VLBW preterm infants.

Purpose of the Study:

  • To compare the prevalence of hypercalcaemia, hypophosphataemia, and hypokalaemia in VLBW preterm infants receiving different parenteral nutrition (PN) amino acid doses.
  • To identify perinatal and nutritional factors associated with electrolyte imbalances in this population.

Main Methods:

  • A retrospective observational study comparing two groups of preterm infants (born <33 weeks gestation, weight <1500g) receiving PN.
  • Group 1 received <3g/kg/day of amino acids; Group 2 received ≥3g/kg/day.
  • Analysis included electrolyte levels, PN composition, and perinatal data, with adjustments for confounders.

Main Results:

  • 114 infants were analyzed (60 low-intake, 54 high-intake).
  • No significant differences in hypercalcaemia, severe hypophosphataemia, or hypokalaemia prevalence were observed between groups (P>.99).
  • A calcium-to-phosphorus ratio >1.05 demonstrated a protective effect against hypophosphataemia (P=.007).

Conclusions:

  • The dose of amino acids in parenteral nutrition (PN) for very low birth weight preterm infants was not associated with increased risk of hypercalcaemia, hypophosphataemia, or hypokalaemia.
  • The findings suggest that current aggressive PN strategies may be safe regarding these specific electrolyte disturbances.
  • Further research may explore other potential risks or benefits of varying amino acid doses in neonatal PN.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
364
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
142
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
40